Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAscendis Pharma A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$1.77 | -$1.19 | -$1.47 |
| Q2 2025 | 11 | -$2.10 | -$0.80 | -$1.34 |
| Q3 2025 | 7 | -$0.80 | -$0.80 | -$0.80 |
| Q4 2025 | 5 | -$0.40 | -$0.40 | -$0.40 |
| Q1 2026 | 4 | $0.26 | $0.26 | $0.26 |
| Q2 2026 | 4 | -$0.28 | -$0.28 | -$0.28 |
| Q3 2026 | 7 | $2.08 | $2.08 | $2.08 |
| Q4 2026 | 4 | $2.65 | $2.65 | $2.65 |
Ascendis Pharma A/S Earnings Date And Information
Ascendis Pharma A/S last posted its earnings results on Thursday, May 1st, 2025. The company reported $-1.66 earnings per share for the quarter, missing analysts' consensus estimates of $-1.56 by $0.1. The company had revenue of 100.95 M for the quarter and had revenue of 363.64 M for the year. Ascendis Pharma A/S has generated $-7 earnings per share over the last year ($-6.53 diluted earnings per share) and currently has a price-to-earnings ratio of -26.31. Ascendis Pharma A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 1st, 2025 based on prior year's report dates.
Ascendis Pharma A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/01/2025 | Q1 2025 | -$1.56 | -$1.58 | -0.02 | $94.81 M | $100.95 M |
| 02/12/2025 | Q4 2024 | -$1.20 | -$0.64 | 0.56 | $119.66 M | $173.92 M |
| 09/30/2024 | Q3 2024 | N/A | -$1.69 | N/A | $71.39 M | $57.83 M |
| 06/29/2024 | Q2 2024 | N/A | -$1.91 | N/A | $82.80 M | $36.00 M |
| 05/02/2024 | Q1 2024 | -$1.57 | -$2.30 | -0.73 | $79.81 M | $95.89 M |
| 02/07/2024 | Q4 2023 | -$2.15 | -$1.53 | 0.62 | $93.73 M | $137.70 M |
| 09/29/2023 | Q3 2023 | N/A | -$2.88 | N/A | $49.05 M | $48.03 M |
| 06/30/2023 | Q2 2023 | N/A | -$2.16 | N/A | $37.24 M | $47.39 M |
| 04/27/2023 | Q1 2023 | -$2.84 | -$1.98 | 0.86 | $21.50 M | $33.59 M |
| 02/16/2023 | Q4 2022 | -$2.50 | -$3.70 | -1.2 | $19.15 M | $22.90 M |
| 09/30/2022 | Q3 2022 | N/A | -$3.03 | N/A | $8.81 M | $15.29 M |
| 06/30/2022 | Q2 2022 | N/A | -$1.46 | N/A | $5.60 M | $6.16 M |
| 05/11/2022 | Q1 2022 | -$2.25 | -$2.21 | 0.04 | $4.55 M | $6.83 M |
| 03/02/2022 | Q4 2021 | -$2.57 | -$1.97 | 0.6 | $2.71 M | $4.90 M |
| 11/10/2021 | Q3 2021 | -$2.60 | -$1.47 | 1.13 | $1.14 M | $1.11 M |
| 08/26/2021 | Q2 2021 | N/A | -$2.50 | N/A | $746.43 K | $1.02 M |
| 03/31/2021 | Q1 2021 | N/A | -$1.17 | N/A | $1.64 M | $746.00 K |
| 12/31/2020 | Q4 2020 | N/A | -$2.60 | N/A | $1.69 M | $535.00 K |
| 11/12/2020 | Q3 2020 | N/A | -$2.31 | N/A | $1.39 M | $2.76 M |
| 06/30/2020 | Q2 2020 | N/A | -$1.97 | N/A | $2.18 M | $1.44 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ascendis Pharma A/S Earnings: FAQ's
Ascendis Pharma A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 1st, 2025 based offlast year's report dates.
The conference call for Ascendis Pharma A/S's latest earnings report can be listened to online.
The conference call transcript for Ascendis Pharma A/S's latest earnings report can be read online.
Ascendis Pharma A/S (:ASND) has a recorded annual revenue of $363.64 M.
Ascendis Pharma A/S (:ASND) has a recorded net income of $-378,084,000.Ascendis Pharma A/S has generated $-6.53 earnings per share over the last four quarters.
Ascendis Pharma A/S (:ASND) has a price-to-earnings ratio of -26.31 and price/earnings-to-growth ratio is -2.39.